Trailing-twelve-month (TTM) revenue is $489.62 Million with a year-over-year growth of +5.18%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-09-30 | $118,088,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-20 |
| Q1 FY2026Period ended 2025-12-31 | $121,219,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q2 FY2026Period ended 2026-03-31 | $120,733,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q3 FY2026Period ended 2026-06-30 | $129,578,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $489,618,000 |
Current P/S: $1,324,890,505 market capitalization ÷ $489,618,000 TTM revenue = 2.71x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-06-30): $129.58M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:47.302Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-09-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-09-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-30 · USD | FY20212021-09-30 · USD | FY20222022-09-30 · USD | FY20232023-09-30 · USD | FY20242024-09-30 · USD | FY20252025-09-30 · USD |
|---|---|---|---|---|---|---|
| Product | $128M | $146M | $151M | $172M | $210M | $311M |
| Service Fee | $78M | $111M | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-30 · USD | FY20212021-09-30 · USD | FY20222022-09-30 · USD | FY20232023-09-30 · USD | FY20242024-09-30 · USD | FY20252025-09-30 · USD |
|---|---|---|---|---|---|---|
| Non-US | $25M | $43M | $42M | $36M | $40M | $43M |
| UNITED STATES | $181M | $214M | $238M | $279M |
$489.62M
$489.62 Million
+5.18%
vs. $465.50M a year ago (TTM)
+15.03%
5 Year compound annual growth rate
1 Year
+5.18%
3 Year
+16.49%
5 Year
+15.03%
10 Year
+4.44%
15 Year
+2.85%
20 Year
+8.73%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $476.67M | +$113.35M | +31.20% |
| 2024 | $363.32M | +$48.86M | +15.54% |
| 2023 | $314.46M | +$34.41M | +12.29% |
| 2022 | $280.05M | +$22.52M | +8.74% |
| 2021 | $257.53M | +$51.59M | +25.05% |
| 2020 |
TTM Growth
+5.18%
3-Year CAGR
+16.49%
5-Year CAGR
+15.03%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:15:47.302Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
| N/A |
| N/A |
| $433M |
| $205.94M |
| ($20.59M) |
| (9.09%) |
| 2019 | $226.53M | +$2.01M | +0.90% |
| 2018 | $224.51M | ($45.50M) | (16.85%) |
| 2017 | $270.01M | ($46.44M) | (14.67%) |
| 2016 | $316.45M | ($80.67M) | (20.31%) |
